BMC Microbiology (May 2010)

Phylogenetic analysis and molecular characteristics of seven variant Chinese field isolates of PRRSV

  • Guo Yunhai,
  • Zhang Hongmei,
  • Luo Jing,
  • Amer Said,
  • Wu Bin,
  • Wang Chengmin,
  • Dong Guoying,
  • Zhao Baohua,
  • He Hongxuan

DOI
https://doi.org/10.1186/1471-2180-10-146
Journal volume & issue
Vol. 10, no. 1
p. 146

Abstract

Read online

Abstract Background Porcine reproductive and respiratory syndrome (PRRS) has now been widely recognized as an economically important disease. The objective of this study was to compare the molecular and biological characteristics of porcine reproductive and respiratory syndrome virus (PRRSV) field isolates in China to those of the modified live virus (MLV) PRRS vaccine and its parent strain (ATCC VR2332). Results Five genes (GP2, GP3, GP4, GP5 and NSP2) of seven isolates of PRRSV from China, designated LS-4, HM-1, HQ-5, HQ-6, GC-2, GCH-3 and ST-7/2008, were sequenced and analyzed. Phylogenetic analyses based on the nucleotide sequence of the ORF2-5 and NSP2 showed that the seven Chinese isolates belonged to the same genetic subgroup and were related to the North American PRRSV genotype. Comparative analysis with the relevant sequences of another Chinese isolate (BJ-4) and North American (VR2332 and MLV) viruses revealed that these isolates have 80.8-92.9% homology with VR-2332, and 81.3-98.8% identity with MLV and 80.7-92.9% with BJ-4. All Nsp2 nonstructural protein of these seven isolates exhibited variations (a 29 amino acids deletion) in comparison with other North American PRRSV isolates. Therefore, these isolates were novel strain with unique amino acid composition. However, they all share more than 97% identity with other highly pathogenic Chinese PRRSV strains. Additionally, there are extensive amino acid (aa) mutations in the GP5 protein and the Nsp2 protein when compared with the previous isolates. Conclusions These results might be useful to study the genetic diversity of PRRSV in China and to track the infection sources as well as for vaccines development.